A Randomized Controlled Phase II Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

被引:0
|
作者
Yang, W., Sr. [1 ]
机构
[1] Guizhou Canc Hosp, Guiyang, Guizhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2171
引用
收藏
页码:E78 / E78
页数:1
相关论文
共 50 条
  • [21] Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
    Cheryl Ho
    Angela M. Davies
    Randeep S. Sangha
    Derick Lau
    Primo Lara
    Helen K. Chew
    Laurel Beckett
    Philip C. Mack
    Jonathan W. Riess
    David R. Gandara
    Investigational New Drugs, 2013, 31 : 1587 - 1591
  • [22] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Suguru Yamada
    Tsutomu Fujii
    Yukihiro Yokoyama
    Hiroki Kawashima
    Osamu Maeda
    Kojiro Suzuki
    Tohru Okada
    Eizaburo Ono
    Junpei Yamaguchi
    Nao Takano
    Hideki Takami
    Masamichi Hayashi
    Yukiko Niwa
    Yoshiki Hirooka
    Yoshiyuki Ito
    Shinji Naganawa
    Yuichi Ando
    Masato Nagino
    Hidemi Goto
    Yasuhiro Kodera
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 815 - 821
  • [23] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
  • [24] The NICE Salvage Study: A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer
    Niwa, Takashi
    Yoshioka, Hiroshige
    Hata, Akito
    Azuma, Koichi
    Tajima, Manabu
    Morita, Mitsunori
    Kogure, Yoshihito
    Akamatsu, Hiroaki
    Ishida, Tadashi
    Katakami, Nobuyuki
    Hoshino, Tomoaki
    Takenoyama, Mitsuhiro
    Takahashi, Kazuhisa
    Kaneda, Hiroyasu
    Tomioka, Hiromi
    Saka, Hideo
    Ando, Masahiko
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1078 - S1079
  • [25] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [26] A Phase II Study of Carboplatin and Nab-Paclitaxel for Advanced Non-Small Cell Lung Cancer with Interstitial Lung Disease (HOT1302)
    Yokouchi, H.
    Asahina, H.
    Oizumi, S.
    Takamura, K.
    Harada, T.
    Harada, M.
    Kanazawa, K.
    Fujita, Y.
    Kojima, T.
    Sugaya, F.
    Tanaka, H.
    Honda, R.
    Ogi, T.
    Kikuchi, E.
    Ikari, T.
    Dosaka-Akita, H.
    Isobe, H.
    Nishimura, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S303 - S303
  • [27] Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
    Yoshimura, Naruo
    Sawa, Kenji
    Nakai, Toshiyuki
    Matsumoto, Yoshiya
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Asai, Kazuhisa
    Yana, Takashi
    Kawaguchi, Tomoya
    Hirata, Kazuto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (12): : 613 - 618
  • [28] A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer
    Yoshihiro Hattori
    Yuko Kono
    Shoichi Itoh
    Takako Inoue
    Yoshiko Urata
    Yoshitaka Kawa
    Rie Tohnai
    Toru Kumagai
    Kazumi Nishino
    Ryuji Uozumi
    Satoshi Morita
    Shunichi Negoro
    Fumio Imamura
    Miyako Satouchi
    BMC Cancer, 20
  • [29] Consolidation chemotherapy with monthly Paclitaxel and Cisplatin (PC) or observation after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer (NSCLC): Randomized phase II study
    Kim, Young Seok
    Choi, Eun Kyung
    Lee, Jung Shin
    Suh, Cheolwon
    Kim, Sang-We
    Kim, Woo-Sung
    Park, Seung Il
    Do, Kyung-Hyun
    Song, Si Yeol
    Park, Jae Won
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S449 - S450
  • [30] A phase I/II study of Carboplatin plus Nab-Paclitaxel in PS 2 pts with advanced non-small-cell lung cancer
    Niwa, Takashi
    Nakashima, Kazuhisa
    Yoshioka, Hiroshige
    Iwamoto, Yasuo
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2017, 28